Vascular parkinsonism-characteristics, pathogenesis and treatment

Nature Reviews Neurology

Volumn 11, Issue 6, 2015, Pages 319-326

  Korczyn, Amos D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROSPINAL FLUID DRAINAGE; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAM; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSONISM; PATHOGENESIS; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASCULAR PARKINSONISM; WHITE MATTER LESION; AGE; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAPHY; MULTIINFARCT DEMENTIA; PARKINSON DISEASE, SECONDARY; PATHOLOGY; PROCEDURES; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASCULAR DISEASES; WHITE MATTER;

AGE FACTORS; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; PARKINSON DISEASE, SECONDARY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASCULAR DISEASES; WHITE MATTER;

EID: 84930572793     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2015.61     Document Type: Review

References (67)

1. Korczyn, A. D. Parkinson's disease: one disease entity or many? J. Neural Transm. Suppl. 56, 107-111 (1999).
2. Critchley, M. Arteriosclerotic parkinsonism. Brain 52, 23-83 (1929).
3. Thompson, P. D. & Marsden, C. D. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease. Mov. Disord. 2, 1-8 (1987).
4. FitzGerald, P. M. & Jankovic, J. Lower body parkinsonism: evidence for vascular etiology. Mov. Disord. 4, 249-260 (1989).
5. Winikates, J. & Jankovic, J. Clinical correlates of vascular parkinsonism. Arch. Neurol. 56, 98-102 (1999).
6. Parkes, J. D. et al. Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa. Q. J. Med. 43, 49-61 (1974).
7. Hunter, R., Smith, J., Thomson, T. & Dayan, A. D. Hemiparkinsonism with infarction of the ipsilateral substantia nigra. Neuropathol. Appl. Neurobiol. 4, 297-301 (1978).
8. Lazzarino, L. G., Nicolai, A. & Toppani, D. Subacute parkinsonism from a single lacunar infarct in the basal ganglia. Acta Neurol. (Napoli) 12, 292-295 (1990).
9. Tolosa, E. S. & Santamariá, J. Parkinsonism and basal ganglia infarcts. Neurology 34, 1516-1518 (1984).
10. Harik, S. I., Al-Hinti, J. T., Archer, R. L. & Angtuaco, E. J. Hemiparkinsonism after unilateral traumatic midbrain hemorrhage in a young woman. Neurol. Clin. Pract. 3, 4-7 (2013).
11. Reider-Groswasser, I., Bornstein, N. M. & Korczyn, A. D. Parkinsonism in patients with lacunar infarcts of the basal ganglia. Eur. Neurol. 35, 46-49 (1995).
12. Ikeda, K,. Kotabe, T., Kanbashi, S. & Kinoshita, M. Parkinsonism in lacunar infarcts of the basal ganglia. Eur. Neurol. 36, 248-249 (1996).
13. Korczyn, A. D. Vascular contribution to dementia in Parkinson's disease. Neurodegener. Dis. 7, 127-130 (2010).
14. Inzelberg, R., Bornstein, N. M., Reider, I. & Korczyn, A. D. Basal ganglia lacunes and parkinsonism. Neuroepidemiology 13, 108-112 (1994).
15. Bhatia, K. P. & Marsden, C. D. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 117, 859-876 (1994).
16. Balash, Y. & Korczyn, A. D. Vascular parkinsonism. Handb. Clin. Neurol. 84, 417-425 (2007).
17. Sibon, I., Fenelon, G., Quinn, N. P. & Tison, F. Vascular parkinsonism. J. Neurol. 251, 513-524 (2004).
18. Leys, D. et al. Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? J. Neurol. Neurosurg. Psychiatry 54, 46-50 (1991).
19. Bornstein, N. M., Halevy, G., Treves, T. & Korczyn, A. D. Cerebral atherosclerosis in Parkinsonian patients. Parkinsonism Relat. Disord. 4, 87-90 (1998).
20. Jellinger, K. A. & Attems, J. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol. 115, 427-436 (2008).
21. Jellinger, K. A. Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study. Acta Neuropathol. 105, 415-419 (2003).
22. Hughes, A. J., Daniel, S. E., Blankson, S. & Lees, A. J. A clinicopathologic study of 100 cases of Parkinson's disease. Arch. Neurol. 50, 140-148 (1993).
23. Glass, P. G. et al. The clinical features of pathologically confirmed vascular parkinsonism. J. Neurol. Neurosurg. Psychiatry 83, 1027-1029 (2012).
24. Gupta, D. & Kuruvilla, A. Vascular parkinsonism: what makes it different? Postgrad. Med. J. 87, 829-836 (2011).
25. Okuda, B., Kawabata, K., Tachibana, H., Kamogawa, K. & Okamoto, K. Primitive reflexes distinguish vascular parkinsonism from Parkinson's disease. Clin. Neurol. Neurosurg. 110, 562-565 (2008).
26. Atchison, P. R., Thompson, P. D., Frackowiak, R. S. & Marsden, C. D. The syndrome of gait ignition failure: a report of six cases. Mov. Disord. 8, 285-292 (1993).
27. Navarro-Otano, J. et al. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease. Parkinsonism Relat. Disord. 20, 192-197 (2014).
28. Rektor, I. et al. Vascular pathology in patients with idiopathic Parkinson's disease. Parkinsonism Relat. Disord. 15, 24-29 (2009).
29. Foltynie, T., Barker, R. & Brayne, C. Vascular parkinsonism: a review of the precision and frequency of the diagnosis. Neuroepidemiology 21, 1-7 (2002).
30. Zijlmans, J. C. et al. EEG findings in patients with vascular parkinsonism. Acta Neurol. Scand. 98, 243-247 (1998).
31. Yamanouchi, H. & Nagura, H. Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. Stroke 28, 965-969 (1997).
32. Wegner, F. et al. Vascular parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic system. J. Neurol. 254, 1743-1745 (2007).
33. Carr, J. Parkinsonism secondary to neurosyphilis. Mov. Disord. 24, 1407 (2009).
34. Fabiani, G., Teive, H. A., Germiniani, F. M., Sá, D. S. & Werneck, L. C. Reversible parkinsonian syndrome in systemic and brain vasculitis. Mov. Disord. 17, 601-604 (2002).
35. Buechner, S., De Cristofaro, M. T., Ramat, S. & Borsini, W. Parkinsonism and Anderson Fabry's disease: a case report. Mov. Disord. 21, 103-107 (2006).
36. Antonini, A. et al. The relationship between cerebral vascular disease and parkinsonism: The VADO study. Parkinsonism Relat. Disord. 18, 775-780 (2012).
37. Bohnen, N. I. & Albin, R. L. White matter lesions in Parkinson disease. Nat. Rev. Neurol. 7, 229-236 (2011).
38. Baezner, H. et al. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 70, 935-942 (2008).
39. de Laat, K. F. et al. Cerebral white matter lesions and lacunar infarcts contribute to the presence of mild parkinsonian signs. Stroke 43, 2574-2579 (2012).
40. Kreisel, S. H. et al. Deterioration of gait and balance over time: the effects of age-related white matter change-the LADIS study. Cerebrovasc. Dis. 35, 544-553 (2013).
41. Kloppenborg, R. P., Nederkoorn, P. J., Geerlings, M. I. & van den Berg, E. Presence and progression of white matter hyperintensities and cognition: a meta-analysis. Neurology 82, 2127-2138 (2014).
42. van Norden, A. G. et al. Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol. BMC Neurol. 11, 29 (2011).
43. Wardlaw, J. M. et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 12, 822-838 (2013).
44. Lorberboym, M., Djaldetti, R., Melamed, E., Sadeh, M. & Lampl, Y. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. J. Nucl. Med. 45, 1688-1693 (2004).
45. Tzen, K. Y., Lu, C. S., Yen, T. C., Wey, S. P. & Ting, G. Differential diagnosis of Parkinson's disease and vascular parkinsonism by 99mTc-TRODAT-1. J. Nucl. Med. 42, 408-413 (2001).
46. 123]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis. Eur. J. Neurol. 21, 1369-e90 (2014).
47. Jakobson Mo, S. et al. Pre-and postsynaptic dopamine SPECT in idiopathic Parkinsonian diseases: a follow-up study. Biomed. Res. Int. 2013, 143532 (2013).
48. Oyanagi, C. et al. Comparison of striatal dopamine D2 receptors in Parkinson's disease and progressive supranuclear palsy patients using 123I-iodobenzofuran single-photon emission computed tomography. J. Neuroimaging 12, 316-324 (2002).
49. Kim, Y. J. et al. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov. Disord. 17, 303-312 (2002).
50. Benítez-Rivero, S. et al. Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 84, 122-129 (2013).
51. Jellinger, K. A. Vascular parkinsonism-neuropathological findings. Acta Neurol. Scand. 105, 414-415 (2002).
52. Auriel, E. et al. Clinical, radiological and pathological correlates of leukoaraiosis. Acta Neurol. Scand. 123, 41-47 (2011).
53. Rosenberg, G. A., Bjerke, M. & Wallin, A. Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment. Stroke 45, 1531-1538 (2014).
54. Wang, H. C., Hsu, J. L. & Leemans, A. Diffusion tensor imaging of vascular parkinsonism: structural changes in cerebral white matter and the association with clinical severity. Arch. Neurol. 69, 1340-1348 (2012).
55. Murray., M. E. et al. Functional impact of white matter hyperintensities in cognitively normal elderly subjects. Arch. Neurol. 67, 1379-1385 (2010).
56. Teodorczuk, A. et al. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol. Med. 40, 603-610 (2010).
57. Ling, M. J., Aggarwal, A. & Morris, J. G. Dopa-responsive parkinsonism secondary to right temporal lobe haemorrhage. Mov. Disord. 17, 402-404 (2002).
58. Zijlmans, J. C., Daniel, S. E., Hughes, A. J., Révész, T. & Lees, A. J. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov. Disord. 19, 630-640 (2004).
59. Krack, P. et al. Ineffective subthalamic nucleus stimulation in levodopa-resistant postischemic parkinsonism. Neurology 54, 2182-2184 (2000).
60. Espay, A. J., Narayan, R. K., Duker, A. P., Barrett, E. T. Jr & de Courten-Myers, G. Lower-body parkinsonism: reconsidering the threshold for external lumbar drainage. Nat. Clin. Pract. Neurol. 4, 50-55 (2008).
61. Tullberg, M. et al. White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination. Acta Neurol. Scand. 105, 417-426 (2002).
62. Akiguchi, I. et al. Shunt-responsive parkinsonism and reversible white matter lesions in patients with idiopathic NPH. J. Neurol. 255, 1392-1399 (2008).
63. Ondo, W. G., Chan, L. L. & Levy, J. K. Vascular parkinsonism: clinical correlates predicting motor improvement after lumbar puncture. Mov. Disord. 17, 91-97 (2002).
64. Tisell, M. et al. Shunt surgery in patients with hydrocephalus and white matter changes. J. Neurosurg. 114, 1432-1438 (2011).
65. Yip, C. W. et al. A prospective pilot study of repetitive transcranial magnetic stimulation for gait dysfunction in vascular parkinsonism. Clin. Neurol. Neurosurg. 115, 887-891 (2013).
66. Caplan, L. R. & Schoene, W. C. Clinical features of subcortical arteriosclerotic encephalopathy (Binswanger disease). Neurology 28, 1206-1215 (1978).
67. Caplan, L. R. Binswanger disease-revisited. Neurology 45, 626-633 (1995).